Alex Therapeutics is a digital health company partnering with pharmaceutical companies to support patients managing complex treatment and disease-related mental health challenges via clinically validated companion apps.

They specialize in oncology and rare diseases, where complex treatment regimens and high mental health comorbidities create significant challenges for patients.

The company aims to provide practical and emotional support throughout patients' healthcare journeys through personalized, evidence-based digital tools that improve quality of life and treatment adherence.

Founded in 2018 by a psychologist and a computational molecular biophysicist, Alex Therapeutics combines psychology and technology with AI and machine learning to develop scalable, regulated digital therapeutics with proven clinical benefits.

With a dedicated team across the EU and US, they focus on delivering high-quality, personalized care to millions worldwide.

Their platform includes digital companion apps designed to empower patients to manage treatment effectively, going beyond reminders by integrating symptom tracking and AI-driven therapy support.

Alex Therapeutics is notable for partnerships with Pfizer, Vicore Pharma, and others in developing digital cognitive behavioral therapies for conditions like anxiety in pulmonary fibrosis and smoking cessation.

The company has an active LinkedIn presence at https://www.linkedin.com/company/alextherapeutics/

There is no specific job postings URL found, but LinkedIn and main website sections indicate opportunities may be available.